---
title: "Kanion Pharmaceutical: Wholly-owned subsidiary's drug receives approval for additional indications"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263255768.md"
description: "Kanion Pharmaceutical announced that its wholly-owned subsidiary Jiangsu Zhongxin Pharmaceutical Co., Ltd. recently received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical Products Administration regarding the new indication for ZX2021 injection for the treatment of metabolic dysfunction-related fatty liver disease"
datetime: "2025-10-29T09:55:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263255768.md)
  - [en](https://longbridge.com/en/news/263255768.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263255768.md)
---

# Kanion Pharmaceutical: Wholly-owned subsidiary's drug receives approval for additional indications

Kanion Pharmaceutical announced that its wholly-owned subsidiary Jiangsu Zhongxin Pharmaceutical Co., Ltd. recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration regarding the new indication for ZX2021 injection for the treatment of metabolic dysfunction-related fatty liver disease

### Related Stocks

- [600557.CN](https://longbridge.com/en/quote/600557.CN.md)

## Related News & Research

- [CMOC Group (CMCLF): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/286625840.md)
- [NYC Health and Hospitals says hackers stole medical data and fingerprints during breach affecting at least 1.8 million people](https://longbridge.com/en/news/286799449.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md)
- [10:30 ETInventHelp Inventor Develops New Line of Candies (SGM-681)](https://longbridge.com/en/news/286931125.md)